Your browser doesn't support javascript.
loading
Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain.
Boix, Francisco; Marín-Rubio, Luis Alberto; Alcoceba, Miguel; García-Álvarez, María; Chillón, María Carmen; García-Sáncez, Sergio; Burillo, Sergio; Terradillos-Sánchez, Pilar; Jiménez-Hernaz, Isabel; Lucas-Sánchez, Sandra; Balanzategui, Ana; Abad-Molina, Cristina; Corral, Rocío; González, Marcos; García-Sanz, Ramón.
Afiliação
  • Boix F; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain. Electronic address: fjboix@saludcastillayleon.es.
  • Marín-Rubio LA; Department of Clinical Analysis, Immunology Unit, Albacete University Hospital Complex, Albacete, Spain.
  • Alcoceba M; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • García-Álvarez M; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Chillón MC; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • García-Sáncez S; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Burillo S; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Terradillos-Sánchez P; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Jiménez-Hernaz I; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Lucas-Sánchez S; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Balanzategui A; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Abad-Molina C; Department of Microbiology and Immunology, Clinical University Hospital of Valladolid (HCUV), Valladolid, Spain.
  • Corral R; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • González M; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • García-Sanz R; Department of Haematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
Hum Immunol ; 82(8): 549-550, 2021 08.
Article em En | MEDLINE | ID: mdl-33965252

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Haplótipos / Alelos / Frequência do Gene / Genética Populacional / Antígenos HLA Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Hum Immunol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Haplótipos / Alelos / Frequência do Gene / Genética Populacional / Antígenos HLA Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Hum Immunol Ano de publicação: 2021 Tipo de documento: Article